Real-time enrollment status for this renal cell carcinoma clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 10:40 PM UTC
| NCT Number | NCT07227402 |
| Recruiting Status | Recruiting |
| Condition | Renal Cell Carcinoma |
| Phase | PHASE3 |
| Target Enrollment | 904 participants |
| Active Locations | 10 sites in the US |
| Sponsor | Merck Sharp & Dohme LLC |
| Last Updated on CT.gov | August 3, 2026 (3 weeks ago) |
As of August 28, 2026: Clinical trial NCT07227402 is currently recruiting participants. This phase3 study for renal cell carcinoma is actively seeking new participants at 10 locations across the United States. The study is sponsored by Merck Sharp & Dohme LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07227402 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 10 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07227402 was last updated 3 weeks ago (August 3, 2026). HelloStudys verifies this status automatically.